Avicenna Biosciences is a biotechnology company that redesigns and optimizes drug candidates.
Avicenna Biosciences has raised $12.0M in total funding. The most recent round was Debt Financing. The last funding was announced in February 2024.
Avicenna Biosciences is headquartered in Durham, United States.
Avicenna Biosciences is a biotechnology company that redesigns and optimizes drug candidates.
Avicenna Biosciences is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avicenna Biosciences — Funding & Investors." VCBacked, February 23, 2024, https://www.vcbacked.co/company/avicenna-biosciences. Accessed August 14, 2026.
VCBacked. (2024). Avicenna Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/avicenna-biosciences
{{cite web |title=Avicenna Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/avicenna-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated